InvestorsHub Logo
Followers 26
Posts 2534
Boards Moderated 0
Alias Born 10/26/2003

Re: DonDonDonDon post# 36590

Sunday, 07/03/2022 4:59:07 PM

Sunday, July 03, 2022 4:59:07 PM

Post# of 43373

A ton of puts were sold the last 2 weeks. Whoever sold the puts will have a lot of incentive to get the share price as close to $2.50 as possible. July options expire on July 15th. As a smallcap biotech, HGEN is an easily manipulatable stock as evidenced by last week's action. That manipulation should reverse and benefit us over the next 2 weeks.

Thanks DonDon. You're trying very hard to win the Top Post of Year award. You definitely get an "A" for effort.

I love when "investors" think they understand the options market. First, one needs to understand for every HGEN option sold there is a buyer of that option who has incentives that are the exact opposite of the seller. The fact you think the sellers of the $2.50 puts who sold them for $1.00 and thus, have a potential basis in shares at $1.50 need the price to move to $2.50 by July 15th is comical. On the other hand, the put buyers, have every incentive to get the price as low as possible given they need HGEN under $1.50 to make any money. One can argue a put buyer might be hedging a long position, however, nobody hedges downside risk on a stock trading at $1.60.

You're also talking about very puny total dollars at risk in these option trades.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.